-
1
-
-
0000155864
-
Myé lite subaiguë compliquée de né vrite optique
-
Devic E. Myé lite subaiguë compliquée de né vrite optique. Bull Med (Paris) 1894; 8:1033-1034.
-
(1894)
Bull Med (Paris)
, vol.8
, pp. 1033-1034
-
-
Devic, E.1
-
3
-
-
10344250945
-
A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis
-
Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364:2106-2112.
-
(2004)
Lancet
, vol.364
, pp. 2106-2112
-
-
Lennon, V.A.1
Wingerchuk, D.M.2
Kryzer, T.J.3
-
4
-
-
23944444890
-
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
-
Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202:473-477.
-
(2005)
J Exp Med
, vol.202
, pp. 473-477
-
-
Lennon, V.A.1
Kryzer, T.J.2
Pittock, S.J.3
-
5
-
-
33745839327
-
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression
-
Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006; 63:964-968.
-
(2006)
Arch Neurol
, vol.63
, pp. 964-968
-
-
Pittock, S.J.1
Weinshenker, B.G.2
Lucchinetti, C.F.3
-
6
-
-
77957572192
-
Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity
-
Kim W, Park MS, Lee SH, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler 2010; 16:1229-1236.
-
(2010)
Mult Scler
, vol.16
, pp. 1229-1236
-
-
Kim, W.1
Park, M.S.2
Lee, S.H.3
-
7
-
-
33745334334
-
Revised diagnostic criteria for neuromyelitis optica
-
Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66:1485-1489.
-
(2006)
Neurology
, vol.66
, pp. 1485-1489
-
-
Wingerchuk, D.M.1
Lennon, V.A.2
Pittock, S.J.3
-
8
-
-
77957601341
-
Neuromyelitis optica: A demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes
-
Parratt JD, Prineas JW. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Mult Scler 2010; 16:1156-1172.
-
(2010)
Mult Scler
, vol.16
, pp. 1156-1172
-
-
Parratt, J.D.1
Prineas, J.W.2
-
9
-
-
0036310181
-
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
-
Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125:1450-1461.
-
(2002)
Brain
, vol.125
, pp. 1450-1461
-
-
Lucchinetti, C.F.1
Mandler, R.N.2
McGavern, D.3
-
10
-
-
60849102769
-
Immunoglobulins and complement in postmortem multiple sclerosis tissue
-
Barnett MH, Parratt JD, Cho ES, Prineas JW. Immunoglobulins and complement in postmortem multiple sclerosis tissue. Ann Neurol 2009; 65:32-46.
-
(2009)
Ann Neurol
, vol.65
, pp. 32-46
-
-
Barnett, M.H.1
Parratt, J.D.2
Cho, E.S.3
Prineas, J.W.4
-
11
-
-
34249711828
-
Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis
-
Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007; 130: 1224-1234.
-
(2007)
Brain
, vol.130
, pp. 1224-1234
-
-
Misu, T.1
Fujihara, K.2
Kakita, A.3
-
12
-
-
34249650146
-
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
-
Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007; 130:1194-1205.
-
(2007)
Brain
, vol.130
, pp. 1194-1205
-
-
Roemer, S.F.1
Parisi, J.E.2
Lennon, V.A.3
-
13
-
-
69549127956
-
Intractable hiccup caused by medulla oblongata lesions: A study of an autopsy patient with possible neuromyelitis optica
-
Kobayashi Z, Tsuchiya K, Uchihara T, et al. Intractable hiccup caused by medulla oblongata lesions: a study of an autopsy patient with possible neuromyelitis optica. J Neurol Sci 2009; 285:241-245.
-
(2009)
J Neurol Sci
, vol.285
, pp. 241-245
-
-
Kobayashi, Z.1
Tsuchiya, K.2
Uchihara, T.3
-
14
-
-
84855959569
-
Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy
-
Barnett MH, Prineas JW, Buckland ME, et al. Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Mult Scler 2012; 18:108-112.
-
(2012)
Mult Scler
, vol.18
, pp. 108-112
-
-
Barnett, M.H.1
Prineas, J.W.2
Buckland, M.E.3
-
15
-
-
77954982900
-
Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study
-
Takano R, Misu T, Takahashi T, et al. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology 2010; 75:208-216.
-
(2010)
Neurology
, vol.75
, pp. 208-216
-
-
Takano, R.1
Misu, T.2
Takahashi, T.3
-
16
-
-
78349297966
-
Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology
-
Lee DH, Metz I, Berthele A, et al. Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology. Neuropathol Appl Neurobiol 2010; 36:685-687.
-
(2010)
Neuropathol Appl Neurobiol
, vol.36
, pp. 685-687
-
-
Lee, D.H.1
Metz, I.2
Berthele, A.3
-
17
-
-
62349119109
-
Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders
-
Magana SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009; 72:712-717.
-
(2009)
Neurology
, vol.72
, pp. 712-717
-
-
Magana, S.M.1
Matiello, M.2
Pittock, S.J.3
-
18
-
-
84856369996
-
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
-
Hinson SR, Romero MF, Popescu BF, et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci USA 2012; 109:1245-1250.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, pp. 1245-1250
-
-
Hinson, S.R.1
Romero, M.F.2
Popescu, B.F.3
-
19
-
-
0345659199
-
Aquaporin-4 square array assembly: Opposing actions of M1 and M23 isoforms
-
Furman CS, Gorelick-Feldman DA, Davidson KG, et al. Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci USA 2003; 100:13609-13614.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 13609-13614
-
-
Furman, C.S.1
Gorelick-Feldman, D.A.2
Davidson, K.G.3
-
20
-
-
79953225158
-
Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding
-
Pisani F, Mastrototaro M, Rossi A, et al. Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding. J Biol Chem 2011; 286:9216-9224.
-
(2011)
J Biol Chem
, vol.286
, pp. 9216-9224
-
-
Pisani, F.1
Mastrototaro, M.2
Rossi, A.3
-
21
-
-
79955541724
-
Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4M1/M23 isoforms and orthogonal arrays
-
Crane JM, Lam C, Rossi A, et al. Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4M1/M23 isoforms and orthogonal arrays. J Biol Chem 2011; 286:16516-16524.
-
(2011)
J Biol Chem
, vol.286
, pp. 16516-16524
-
-
Crane, J.M.1
Lam, C.2
Rossi, A.3
-
22
-
-
84455169951
-
Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica
-
Ratelade J, Bennett JL, Verkman AS. Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica. J Biol Chem 2011; 286:45156-45164.
-
(2011)
J Biol Chem
, vol.286
, pp. 45156-45164
-
-
Ratelade, J.1
Bennett, J.L.2
Verkman, A.S.3
-
23
-
-
58149171974
-
Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
-
Hinson SR, Roemer SF, Lucchinetti CF, et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 2008; 205:2473-2481.
-
(2008)
J Exp Med
, vol.205
, pp. 2473-2481
-
-
Hinson, S.R.1
Roemer, S.F.2
Lucchinetti, C.F.3
-
24
-
-
77956383249
-
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury
-
Marignier R, Nicolle A, Watrin C, et al. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain 2010; 133:2578-2591.
-
(2010)
Brain
, vol.133
, pp. 2578-2591
-
-
Marignier, R.1
Nicolle, A.2
Watrin, C.3
-
25
-
-
72949114659
-
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
-
Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009; 66:630-643.
-
(2009)
Ann Neurol
, vol.66
, pp. 630-643
-
-
Bradl, M.1
Misu, T.2
Takahashi, T.3
-
26
-
-
77249090731
-
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
-
Saadoun S, Waters P, Bell BA, et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010; 133:349-361.
-
(2010)
Brain
, vol.133
, pp. 349-361
-
-
Saadoun, S.1
Waters, P.2
Bell, B.A.3
-
27
-
-
0033966090
-
Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke
-
Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000; 6:159-163.
-
(2000)
Nat Med
, vol.6
, pp. 159-163
-
-
Manley, G.T.1
Fujimura, M.2
Ma, T.3
-
28
-
-
84355166544
-
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
-
Zhang H, Bennett JL, Verkman AS. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol 2011; 70:943-954.
-
(2011)
Ann Neurol
, vol.70
, pp. 943-954
-
-
Zhang, H.1
Bennett, J.L.2
Verkman, A.S.3
-
29
-
-
79958765901
-
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
-
Jarius S, Paul F, Franciotta D, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci 2011; 306:82-90.
-
(2011)
J Neurol Sci
, vol.306
, pp. 82-90
-
-
Jarius, S.1
Paul, F.2
Franciotta, D.3
-
30
-
-
72949093353
-
Intrathecal pathogenic antiaquaporin-4 antibodies in early neuromyelitis optica
-
Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic antiaquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009; 66:617-629.
-
(2009)
Ann Neurol
, vol.66
, pp. 617-629
-
-
Bennett, J.L.1
Lam, C.2
Kalluri, S.R.3
-
31
-
-
80053457747
-
Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years
-
Kim SH, Kim W, Li XF, et al. Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol 2011; 68:1412-1420.
-
(2011)
Arch Neurol
, vol.68
, pp. 1412-1420
-
-
Kim, S.H.1
Kim, W.2
Li, X.F.3
-
32
-
-
79952762854
-
Interleukin 6 signaling promotes antiaquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
-
Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes antiaquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci USA 2011; 108:3701-3706.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 3701-3706
-
-
Chihara, N.1
Aranami, T.2
Sato, W.3
-
33
-
-
71849113120
-
Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis
-
Uzawa A, Mori M, Ito M, et al. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis. J Neurol 2009; 256:2082-2084.
-
(2009)
J Neurol
, vol.256
, pp. 2082-2084
-
-
Uzawa, A.1
Mori, M.2
Ito, M.3
-
34
-
-
26444619864
-
IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis
-
Kaplin AI, Deshpande DM, Scott E, et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 2005; 115:2731-2741.
-
(2005)
J Clin Invest
, vol.115
, pp. 2731-2741
-
-
Kaplin, A.I.1
Deshpande, D.M.2
Scott, E.3
-
35
-
-
0031920882
-
IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein
-
Okuda Y, Sakoda S, Bernard CC, et al. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int Immunol 1998; 10:703-708.
-
(1998)
Int Immunol
, vol.10
, pp. 703-708
-
-
Okuda, Y.1
Sakoda, S.2
Bernard, C.C.3
-
36
-
-
62349105479
-
Distribution of the AQP4 water channel in normal human tissues: Protein and tissue microarrays reveal expression in several new anatomical locations, including the prostate gland and seminal vesicles
-
Mobasheri A, Marples D, Young IS, et al. Distribution of the AQP4 water channel in normal human tissues: protein and tissue microarrays reveal expression in several new anatomical locations, including the prostate gland and seminal vesicles. Channels (Austin) 2007; 1:29-38.
-
(2007)
Channels (Austin)
, vol.1
, pp. 29-38
-
-
Mobasheri, A.1
Marples, D.2
Young, I.S.3
-
37
-
-
68149148572
-
Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis
-
Quintana A, Muller M, Frausto RF, et al. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J Immunol 2009; 183:2079-2088.
-
(2009)
J Immunol
, vol.183
, pp. 2079-2088
-
-
Quintana, A.1
Muller, M.2
Frausto, R.F.3
-
38
-
-
70349883885
-
Spinal cord lesions in patients with neuromyelitis optica: A retrospective long-term MRI follow-up study
-
Krampla W, Aboul-Enein F, Jecel J, et al. Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol 2009; 19:2535-2543.
-
(2009)
Eur Radiol
, vol.19
, pp. 2535-2543
-
-
Krampla, W.1
Aboul-Enein, F.2
Jecel, J.3
-
39
-
-
33644901308
-
Brain abnormalities in neuromyelitis optica
-
Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63:390-396.
-
(2006)
Arch Neurol
, vol.63
, pp. 390-396
-
-
Pittock, S.J.1
Lennon, V.A.2
Krecke, K.3
-
40
-
-
70350056914
-
"cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica
-
Ito S, Mori M, Makino T, et al. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009; 66:425-428.
-
(2009)
Ann Neurol
, vol.66
, pp. 425-428
-
-
Ito, S.1
Mori, M.2
Makino, T.3
-
41
-
-
84860780841
-
Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders
-
[Epub ahead of print]
-
Banker P, Sonni S, Kister I, et al. Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders. Mult Scler 2011. [Epub ahead of print]
-
(2011)
Mult Scler
-
-
Banker, P.1
Sonni, S.2
Kister, I.3
-
42
-
-
77955456303
-
Interferon beta treatment in neuromyelitis optica: Increase in relapses and aquaporin 4 antibody titers
-
Palace J, Leite MI, Nairne A, Vincent A. Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol 2010; 67:1016-1017.
-
(2010)
Arch Neurol
, vol.67
, pp. 1016-1017
-
-
Palace, J.1
Leite, M.I.2
Nairne, A.3
Vincent, A.4
-
43
-
-
78049510106
-
IFNb-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
-
Shimizu J, Hatanaka Y, Hasegawa M, et al. IFNb-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 2010; 75:1423-1427.
-
(2010)
Neurology
, vol.75
, pp. 1423-1427
-
-
Shimizu, J.1
Hatanaka, Y.2
Hasegawa, M.3
-
44
-
-
84862908479
-
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
-
Min JH, Kim BJ, Lee KH. Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler 2012; 18:113-115.
-
(2012)
Mult Scler
, vol.18
, pp. 113-115
-
-
Min, J.H.1
Kim, B.J.2
Lee, K.H.3
-
45
-
-
80053583158
-
Impact of rituximab on relapse rate and disability in neuromyelitis optica
-
Bedi GS, Brown AD, Delgado SR, et al. Impact of rituximab on relapse rate and disability in neuromyelitis optica. Mult Scler 2011; 17:1225-1230.
-
(2011)
Mult Scler
, vol.17
, pp. 1225-1230
-
-
Bedi, G.S.1
Brown, A.D.2
Delgado, S.R.3
-
46
-
-
80055095675
-
Azathioprine: Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
-
Costanzi C, Matiello M, Lucchinetti CF, et al. Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica. Neurology 2011; 77:659-666.
-
(2011)
Neurology
, vol.77
, pp. 659-666
-
-
Costanzi, C.1
Matiello, M.2
Lucchinetti, C.F.3
-
47
-
-
79958112517
-
Transient increases in antiaquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels
-
Nakashima I, Takahashi T, Cree BA, et al. Transient increases in antiaquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels. J Clin Neurosci 2011; 18:997-998.
-
(2011)
J Clin Neurosci
, vol.18
, pp. 997-998
-
-
Nakashima, I.1
Takahashi, T.2
Cree, B.A.3
-
48
-
-
34249821083
-
Relapsing neuromyelitis optica responsive to glatiramer acetate treatment
-
Gartzen K, Limmroth V, Putzki N. Relapsing neuromyelitis optica responsive to glatiramer acetate treatment. Eur J Neurol 2007; 14:e12-e13.
-
(2007)
Eur J Neurol
, vol.14
-
-
Gartzen, K.1
Limmroth, V.2
Putzki, N.3
-
49
-
-
35448977649
-
Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica
-
Okada K, Tsuji S, Tanaka K. Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica. Intern Med 2007; 46:1671-1672.
-
(2007)
Intern Med
, vol.46
, pp. 1671-1672
-
-
Okada, K.1
Tsuji, S.2
Tanaka, K.3
-
50
-
-
33846528659
-
Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica
-
Watanabe S, Nakashima I, Misu T, et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007; 13:128-132.
-
(2007)
Mult Scler
, vol.13
, pp. 128-132
-
-
Watanabe, S.1
Nakashima, I.2
Misu, T.3
-
51
-
-
33745858352
-
Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease)
-
Weinstock-Guttman B, Ramanathan M, Lincoff N, et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 2006; 63:957-963.
-
(2006)
Arch Neurol
, vol.63
, pp. 957-963
-
-
Weinstock-Guttman, B.1
Ramanathan, M.2
Lincoff, N.3
-
52
-
-
84855881248
-
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica
-
[Epub ahead of print]
-
Tradtrantip L, Zhang H, Saadoun S, et al. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 2011. [Epub ahead of print]
-
(2011)
Ann Neurol
-
-
Tradtrantip, L.1
Zhang, H.2
Saadoun, S.3
-
53
-
-
84860898728
-
Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica
-
[Epub ahead of print]
-
Tradtrantip L, Zhang H, Anderson MO, et al. Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J 2012. [Epub ahead of print]
-
(2012)
FASEB J
-
-
Tradtrantip, L.1
Zhang, H.2
Anderson, M.O.3
|